Supervision of Research Program Clause Samples

The 'Supervision of Research Program' clause establishes the responsibility and authority of a designated supervisor or committee to oversee the progress and quality of a research project or program. Typically, this clause outlines the supervisor's duties, such as providing guidance, monitoring milestones, and ensuring compliance with institutional or funding requirements. By clearly defining supervisory roles and expectations, the clause helps maintain academic standards, supports researcher development, and ensures the research stays on track and meets its objectives.
Supervision of Research Program. TSRI agrees that the Research Program at TSRI shall be conducted by or under the direct supervision of the Principal Investigator. In the event that the Principal Investigator leaves TSRI, or terminates his/her involvement in the Research Program, TSRI shall use its best efforts to find a replacement Principal Investigator acceptable to Sponsor, which acceptance shall not be unreasonably withheld. In the event that TSRI shall fail to appoint a replacement Principal Investigator reasonably acceptable to Sponsor, Sponsor shall have a right to terminate this Agreement upon delivery to TSRI of written notice of termination pursuant to this Section 2.2, which notice must be delivered to TSRI not more than ninety (90) days after delivery by TSRI to Sponsor of the name of the proposed replacement Principal Investigator.
View SourceView Similar (8)
Supervision of Research Program. TSRI agrees that the Research Program at TSRI shall be conducted by or under the direct supervision of the Principal Investigator. In the event that the Principal Investigator leaves TSRI, or terminates his/her involvement in the Research Program, TSRI shall use its best efforts to find a replacement Principal Investigator acceptable to Sponsor, which acceptance shall not be unreasonably withheld. In the event that TSRI shall fail to appoint a replacement Principal Investigator reasonably acceptable to Sponsor, Sponsor shall have a right to terminate this Agreement upon delivery to TSRI of written notice of intent to terminate pursuant to this Section 2.2, which notice must be delivered to TSRI not less than [***] nor more than [***] after delivery by TSRI to Sponsor of the name of the replacement Principal Investigator.
View SourceView Similar (3)
Supervision of Research Program. Scripps agrees that the Research Program at Scripps shall be conducted by or under the direct supervision of the following Principal Investigator: ▇▇. ▇▇▇ ▇▇▇▇▇▇▇. In the event that the Principal Investigator leaves Scripps, or terminates his involvement in the Research Program, Scripps shall use its best efforts to find a replacement Principal Investigator acceptable to Optionee, which acceptance shall not be unreasonably withheld. In the event that Scripps shall fail to appoint a replacement Principal Investigator reasonably acceptable to Optionee, Optionee shall have a right to terminate this Agreement upon delivery to Scripps of written notice of intent to terminate pursuant to this Section 2.2, which notice must be delivered to Scripps not less than 30 days nor more than 90 days after delivery by Scripps to Optionee of the name of the replacement Principal Investigator.
View SourceView Similar (2)
Supervision of Research Program. 3 2.3 Reports ..................................................... 4 2.4 Contributions of Parties to Research Program ................ 4
View Source
Supervision of Research Program. EVMS agrees that the Research Program at EVMS shall be conducted by or under the direct supervision of the following Principal Investigator: Dr.
View Source
Supervision of Research Program. Scripps agrees that the Research Program at Scripps shall be conducted by or under the direct supervision of the following Principal Investigator: ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇, M.
View Source
Supervision of Research Program. TSRI agrees that the Research Program at TSRI shall be conducted by or under the direct supervision of the Principal Investigator and in conjunction with the joint steering committee (JSC), as set forth in the Research Program. In the event that the Principal Investigator leaves TSRI, or terminates his/her involvement in the Research Program, TSRI shall use its best efforts to find a replacement Principal Investigator acceptable to Sponsor within 60 days, which acceptance shall not be unreasonably withheld. In the event that TSRI shall fail to appoint a replacement Principal Investigator reasonably acceptable to Sponsor, Sponsor shall have a right to terminate this Agreement upon delivery to TSRI of written notice of intent to terminate pursuant to this Section 2.2, which notice must be delivered to TSRI no more than 90 days after delivery by TSRI to Sponsor of the name of the replacement Principal Investigator.
View Source

Related to Supervision of Research Program

  • Research Program The term “

  • Development Program A. Development activities to be undertaken (Please break activities into subunits with the date of completion of major milestones) B. Estimated total development time

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).

  • DEVELOPMENT OR ASSISTANCE IN DEVELOPMENT OF SPECIFICATIONS REQUIREMENTS/ STATEMENTS OF WORK

  • Collaboration activities 4.1 The Collaboration Suppliers will perform the Collaboration Activities and all other obligations of this Agreement in accordance with the Detailed Collaboration Plan. 4.2 The Collaboration Suppliers will provide all additional cooperation and assistance as is reasonably required by the Buyer to ensure the continuous delivery of the services under the Call-Off Contract. 4.3 The Collaboration Suppliers will ensure that their respective subcontractors provide all cooperation and assistance as set out in the Detailed Collaboration Plan.